Phibro Animal Health sees FY24 adjusted EPS $1.34-$1.48, consensus $1.55

Sees net sales of $1.05 billion to $1.10 billion, 6% growth, consensus $1.21B; Net income of $36 million to $42 million; Diluted EPS of $0.89 to $1.04; Adjusted EBITDA of $124 million to $132 million, 15% growth; Adjusted net income of $55 million to $60 million, 18% growth; Adjusted diluted EPS of $1.34 to $1.48, 18% growth; Adjusted effective tax rate of 24% to 26%.